Utah Administrative Code
Topic - Health
Title R384 - Population Health, Health Promotion and Prevention
Rule R384-210 - Co-prescription Guidelines - Reporting
Section R384-210-2 - Guidelines for the Issuance of a Prescription for an Opioid Antagonist Along With a Prescription for an Opioid
Universal Citation: UT Admin Code R 384-210-2
Current through Bulletin 2024-06, March 15, 2024
(1) Co-prescribing guidelines are applicable when prescribing opioids.
(2) Prescribers are encouraged to co-prescribe and opioid antagonist, such as naloxone; and to provide education on how to recognize an opioid overdose to patients, patient's household members and/or close contacts, when available, if factors exist that increase risk for opioid overdose, and households where preschool age children live or visit, whenever opiate medication is prescribed. Risks for opioid overdose include:
(a) a
known history of overdose;
(b) a
known history of substance use disorder;
(c) a mental health condition that could make
a patient susceptible to overdose;
(d) a risk for returning to a high dose to
which they are no longer tolerant (e.g., patients recently released from
prison);
(e) unstable medical
conditions, such as respiratory disease, sleep apnea, cognitive decline medical
conditions, or other comorbidities that make a patient susceptible to opioid
toxicity, respiratory distress or overdose;
(f) higher opioid dosages such as a dose
greater than or equal to 50 Morphine Milligram Equivalents/day; and
(g) concurrent benzodiazepine use.
Disclaimer: These regulations may not be the most recent version. Utah may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
